Epidemic strain YC2014 of porcine epidemic diarrhea virus could provide piglets against homologous c

来源 :2016第六届中国兽药大会(中国畜牧兽医学会动物药品学分会第五届全国会员代表大会暨2016学术年会、中国微生物学会兽医微 | 被引量 : 0次 | 上传用户:wangctm
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Porcine epidemic diarrhea virus (PEDV) is the main causative agent of porcine epidemic diarrhea (PED).Since December 2010, a large-scale outbreak of diarrhea has been observed in swine farms in China.A PEDV strain, YC2014, was isolated from intestinal samples of suckling piglets with acute diarrhea in 2014.The complete genomic sequence of YC2014 and the nucleotide sequence of S gene were aligned with sequences of published isolates using MEGA 5.1 software.The immune protective efficiency of YC2014 were determined by testing PEDV neutralizing antibodies in sera, the colostrum and the milk on 7th day after farrowing of the immunized sows.The diarrhea symptoms of piglets after challenge were also observed.Phylogenetic analysis of the complete genomic sequence of YC2014 and the nucleotide sequence of S gene demonstrated that the YC2014 PEDV strain was clustered with the PEDV epidemic strains, with >99% nucleotide identity to these PEDV strains.The S gene sequence of YC2014 shared only 93.9%~94.4% identities with classical CV777, DR13 and JS2008 strains, with 15 nucleotide insertion in three sites and 3 nucleotide deletion in one site.The amino acid (AA)sequence of S gene of YC2014 shared only 92.8%~93.4% identities with classical CV777, DR13and JS2008 strains, with 5 AA insertion in two sites and 1 AA deletion in one site.In the immune protective efficiency tests, the neutralizing antibody titers in sera, the colosmm and the milk on 7th day after farrowing of the inactivated YC2014 PEDV strain immunized group were significantly higher than the inactivated CV777 immunized group and the inactivated DR13 immunized group (P < 0.05).The traditional inactivated PEDV vaccines made from CV777 or DR13 could not protect piglets from YC2014 challenge, while inactivated YC2014 could provide piglets with 100% protection against YC2014 challenge.It is critical for future pathogenic and antigenic studies, as well as for the development of effective preventive and control vaccines against PEDV.
其他文献
噬菌体作为一种细菌病毒,能够特异性侵染并裂解细菌.近年来,随着抗生素的广泛使用,细菌的耐药性日益严重,噬菌体作为抗菌制剂用于耐药菌的防治研究引起高度重视.T4类噬菌体属于有尾噬菌体,通过其长尾丝末端的蛋白gp37或gp38识别宿主表面的特异性受体,并与之可逆性结合,进而启动噬菌体侵染宿主菌的过程.尾丝蛋白识别受体的特异性决定了噬菌体的宿主谱.在前期研究工作中,从鸡场粪便中分离到一株噬菌体Bp7,具
奶牛乳房炎是奶牛场危害最大、最常见的顽固性疾病之一,给奶牛业造成巨大的经济损失.导致奶牛乳房炎的病因复杂,病原达150多种,其中无乳链球菌和金黄色葡萄球菌为其主要的传染性的病原体之一.为评价疫苗的免疫效果,采用相同的菌体抗原,分别添加不同的铝胶佐剂制备两组(疫苗A和疫苗B)奶牛乳房炎无乳链球菌和金黄色葡萄球菌二联灭活疫苗,并开展安全性试验和效力评价试验.安全性试验结果显示,疫苗A和疫苗B免疫家兔分
鸡传染性鼻炎是由副鸡嗜血杆菌(Haemophilus paragallinarum)引起的一种急性上呼吸道传染病.副鸡嗜血杆菌分为A、B、C3个血清型,不同的血清型之间几乎无交叉保护.本研究将实验室制备的鸡传染性鼻炎三价(A型221株+B型B4株+C型H-18株)灭活疫苗与国内外同类产品特点、安全性、免疫效果进行比较,旨在为鸡传染性鼻炎病的防控提供参考.安全性比较试验结果:每批疫苗分别经腿部肌肉注
奶牛乳房炎是奶牛常见的疾病之一,是由病原微生物入侵或机械性损伤等因素所致,危害严重.该病的病原微生物复杂多样,链球菌为主要传染性病原之一,包括无乳链球菌、停乳链球菌和乳房链球菌.近年来,由于细菌耐药性、药物残留给本病的治疗带来诸多困难,疫苗是防治本病最为安全有效的手段,迫切需要研制出免疫效果好的疫苗.但由于链球菌各个血清型之间无交叉保护力,且该病病原复杂,因此链球菌性奶牛乳房炎疫苗的研制还存在着的
Infectious bronchitis (IB) is an acute and highly contagious viral respiratory disease of chickens and vaccination is the main method for disease control.The S1 protein, which contains several virus n
哺乳动物的TANK结合激酶1(TANK-bindingkinase1,TBK1)是RIG-I样受体(RLR)介导的Ⅰ型干扰素通路中的重要调控因子,RLR通路被激活后,TBK1通过磷酸化下游的干扰素调节因子3/7(IRF3/7)实现对Ⅰ型干扰素的调控.在RIG-I基因缺失的鸡细胞中,对以MDA5-STING-IFNβ为核心的RLR通路虽有初步研究,但鸡是否具有TBK1基因、TBK1基因能否在此通路中
Since February 2013, H7N9 influenza virus, causing human infections with high mortality in China, has raised public concerns.The H7N9 viruses are found to diverge into distinct genotypes as other infl
对2012-2015年从中国9个省份的己免疫鸡场中分离到的42株H9N2亚型AIV及近年流感数据库中新增410株中国分离株HA序列和306株全基因序列比较和抗原性分析.42株H9N2亚型AIV的HA基因的核苷酸相似性为86.7-99.7%,与经典疫苗株的相似性为88.6-92.6%.中国H9N2亚型禽流感病毒流行株有99.1%属于h9.4.2分支,其中99.3%为h9.4.2.5分支,98.2%的
山东莘县某肉鸡养殖场出现了以心包积液、出血性肝炎为特征的疾病,从采集的病料中分离病毒后,命名为SDSX株.本研究对分离的毒株进行PCR扩增、血凝试验、ELD50和EID50测定、Hexon基因序列测定与分析以及对人工感染试验进行组织病理学观察、抗体水平检测等一系列试验.结果显示,分离的毒株不能凝集鸡和鸭的红细胞,但能够凝集大鼠的红细胞,ELD50为10-3.17/0.2mL.组织学变化显示肝细胞纤
研发并制备有效、广谱的H7亚型禽流感疫苗,以应对H7N9等人禽共患禽流感,具有重要的公共卫生学意义。通过对比分析,我们选取了两株具有代表性H7亚型A/Netherlands/219/2003 (H7N7)、A/Anhui/1/2013 (H7N9)的HA基因,运用反向遗传技术与人流感标准疫苗毒株PR8的内部基因重组,并成功获得H7N1/PR8(NL)、H7N9/PR8(AH)两个重组毒株,制备全病